Digging into KKR’s $1.2b-plus deal for Lightyear’s Therapy Brands, Another big LBO opportunity emerges in Medline Industries

Behind KKR's $1.25 billion Therapy Brands' buyout and Medline Industries is exploring a sale that could value it as much as $30 billion.

To read this article, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to read this article and more for free.

Share this